Relmada Therapeutics (RLMD) Operating Margin (2012 - 2023)
Relmada Therapeutics (RLMD) posted Operating Margin of -2130.62% for Q4 2023, up 1449.04 percentage points from -3579.66% a year earlier but down 413.36 percentage points from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Operating Margin (2012 - 2023) Analysis & Trends
For FY2023, Relmada Therapeutics' Operating Margin came in at -2012.97%, up 5762.18 percentage points from FY2022.
- In prior years, Relmada Therapeutics' Operating Margin was -7775.15% in FY2022 (+14549.71 pp) and -22324.86% in FY2021.
- Quarterly Operating Margin has run from a low of -95047.20% in Q4 2021 to a high of -1717.26% in Q3 2023 over five years.
- On a year-over-year basis, Operating Margin has increased in each of the last five quarters, with an average year-over-year change of +24372.45 percentage points over the last five quarters.
- According to Business Quant data, Operating Margin for the three prior quarters was -1717.26% (Q3 2023), -1908.95% (Q2 2023) and -5204.74% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Relmada Therapeutics | 473.10 Mn | -85.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -2,130.62% |
| Sep 30, 2023 | -1,717.26% |
| Jun 30, 2023 | -1,908.95% |
| Mar 31, 2023 | -5,204.74% |
| Dec 31, 2022 | -3,579.66% |
| Sep 30, 2022 | -14,564.87% |
| Jun 30, 2022 | -11,051.05% |
| Mar 31, 2022 | -12,160.73% |
| Dec 31, 2021 | -95,047.20% |
| Dec 31, 2020 | -9,329.66% |
| Sep 30, 2020 | -4,729.86% |
| Sep 30, 2019 | -9,777.96% |
| Mar 31, 2019 | -16,952.16% |
| Sep 30, 2017 | -177.52% |
| Jun 30, 2017 | -865,477.67% |
| Mar 31, 2017 | -482,653.70% |
| Jun 30, 2016 | -163,632.54% |
| Mar 31, 2016 | -353,096.14% |
| Jun 30, 2015 | -925,710.10% |
| Mar 31, 2015 | -198,797.52% |
API Access
Relmada Therapeutics Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();